Cargando…
A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line
BACKGROUND: Enhancement of tumor cell sensitivity may help facilitate a reduction in drug dosage using conventional chemotherapies. Consequently, it is worthwhile to search for adjuvants with the potential of increasing chemotherapeutic drug effectiveness and improving patient quality of life. Natur...
Autores principales: | Castañeda, Diana M, Pombo, Luis Miguel, Urueña, Claudia Patricia, Hernandez, John Fredy, Fiorentino, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353181/ https://www.ncbi.nlm.nih.gov/pubmed/22490328 http://dx.doi.org/10.1186/1472-6882-12-38 |
Ejemplares similares
-
Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model
por: Urueña, Claudia, et al.
Publicado: (2013) -
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
por: Lasso, Paola, et al.
Publicado: (2020) -
Safety Evaluation in Healthy Colombian Volunteers of P2Et Extract Obtained from Caesalpinia spinosa: Design 3+3 Phase I Clinical Trial
por: Duran, María I, et al.
Publicado: (2022) -
Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)
por: Ballesteros-Ramírez, Ricardo, et al.
Publicado: (2023) -
Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa
por: Ballesteros-Ramírez, R., et al.
Publicado: (2020)